Australia's Novotech has sold off a 30% stake to private equity firm Mercury Capital, planning to use the money to spread its reach across Asia.
Royal DSM in June will open a new biologics plant in Brisbane, the first custom mammalian-based biopharmaceutical manufacturing facility in Australia.
Medtronic ($MDT) must deal with an Australian safety advisory concerning some potential problems with its Paradigm insulin pumps.
A blood test to determine a patient's suicide risk may be within reach. Scientists at the University of New South Wales in Australia and colleagues in Sweden believe they've come up with a viable diagnostic biomarker: higher-than-normal levels of the neurotransmitter quinolinic acid.
On Feb. 15, Australian boys began receiving Gardasil as part of a $21 million program geared toward vaccinating 12- and 13-year-olds.
Researchers at Australia's University of Queensland have developed a vaccine-delivery system that dispenses with needle and syringe.
Australian CRO Clinical Network Services has acquired New Zealand's Beltas, a former partner and provider of wide-ranging trial services.
Pradaxa, the warfarin alternative from Boehringer Ingelheim, is again under fire only weeks after the FDA released information that the blood thinner was at least as safe as the drug it seeks to supplant.
DSM Pharmaceutical Products has won another contract to feed the new biologics plant it is building with the help of government support in Australia.
Scientists in Australia say they've taken the first step toward developing a microbicide vaginal cream derived from cow's milk, of all things, that could protect women from contracting HIV during sex.